Invesaro

Stocks Comparison

Evolent Health vs Franklin Covey: revenue, profit, margins and growth compared

Evolent Health brought in $1.9B of revenue in fiscal 2025, Franklin Covey $267.1M in fiscal 2025. Revenue changed by -26.6% at Evolent Health and -7.0% at Franklin Covey on the year before, so Franklin Covey grew faster. Evolent Health kept -28.5% of its revenue as net profit, Franklin Covey 1.1%.

Side by side, latest fiscal year

EVHFC
Fiscal year endedFY2025 (December 31, 2025)FY2025 (August 31, 2025)
Revenue$1.9B$267.1M
Revenue growth-26.6%-7.0%
Net income-$534.5M$3.1M
Net margin-28.5%1.1%
Free cash flown/a$20.7M
Free cash flow marginn/a7.8%
Earnings per share (diluted)-$5.07$0.24
Cash$151.9M$31.7M
Debt$970.5Mn/a
Price to earningsn/a72.1
Market value$408.1M$195.5M
Dividend yieldn/an/a
Rank by revenue in sector#361 of 778 · Consumer discretionary#632 of 778 · Consumer discretionary

Over the years

Revenue
EVH FY2018: $627.1MEVH FY2019: $846.4MEVH FY2020: $924.6MEVH FY2021: $908MEVH FY2022: $1.4BEVH FY2023: $2BEVH FY2024: $2.6BEVH FY2025: $1.9BFC FY2018: $209.8MFC FY2019: $225.4MFC FY2020: $198.5MFC FY2021: $224.2MFC FY2022: $262.8MFC FY2023: $280.5MFC FY2024: $287.2MFC FY2025: $267.1MFY18FY19FY20FY21FY22FY23FY24FY25
EVH $1.9BFC $267.1M
Net income
EVH FY2018: -$52.7MEVH FY2019: -$302MEVH FY2020: -$334.2MEVH FY2021: -$37.6MEVH FY2022: -$19.2MEVH FY2023: -$113MEVH FY2024: -$61.6MEVH FY2025: -$534.5MFC FY2018: -$5.9MFC FY2019: -$1MFC FY2020: -$9.4MFC FY2021: $13.6MFC FY2022: $18.4MFC FY2023: $17.8MFC FY2024: $23.4MFC FY2025: $3.1MFY18FY19FY20FY21FY22FY23FY24FY25
EVH -$534.5MFC $3.1M
Net margin
EVH FY2018: -8.4%EVH FY2019: -35.7%EVH FY2020: -36.1%EVH FY2021: -4.1%EVH FY2022: -1.4%EVH FY2023: -5.8%EVH FY2024: -2.4%EVH FY2025: -28.5%FC FY2018: -2.8%FC FY2019: -0.5%FC FY2020: -4.8%FC FY2021: 6.1%FC FY2022: 7.0%FC FY2023: 6.3%FC FY2024: 8.1%FC FY2025: 1.1%FY18FY19FY20FY21FY22FY23FY24FY25
EVH -28.5%FC 1.1%
Revenue growth
EVH FY2019: +35.0%EVH FY2020: +9.2%EVH FY2021: -1.8%EVH FY2022: +48.9%EVH FY2023: +45.3%EVH FY2024: +30.1%EVH FY2025: -26.6%FC FY2019: +7.4%FC FY2020: -11.9%FC FY2021: +13.0%FC FY2022: +17.3%FC FY2023: +6.7%FC FY2024: +2.4%FC FY2025: -7.0%FY19FY20FY21FY22FY23FY24FY25
EVH -26.6%FC -7.0%
Free cash flow
EVH FY2018: -$60.2MEVH FY2019: -$78.2MFC FY2018: $10.3MFC FY2019: $26.3MFC FY2020: $23.4MFC FY2021: $44.6MFC FY2022: $49.1MFC FY2023: $31.2MFC FY2024: $56.6MFC FY2025: $20.7MFY18FY19FY20FY21FY22FY23FY24FY25
EVH -$78.2MFC $20.7M

Fiscal years as each company reports them; the two may end in different months.

Questions about Evolent Health and Franklin Covey

Which is bigger by revenue, Evolent Health or Franklin Covey?

Evolent Health is bigger by revenue: $1.9B in fiscal 2025, against $267.1M for Franklin Covey in fiscal 2025.

Which keeps more of its revenue as profit, Evolent Health or Franklin Covey?

Evolent Health had a net margin of -28.5% in fiscal 2025; Franklin Covey had 1.1% in fiscal 2025.

Which grew revenue faster, Evolent Health or Franklin Covey?

In their latest fiscal years revenue changed by -26.6% at Evolent Health and -7.0% at Franklin Covey.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies